Results 51 to 60 of about 5,590,035 (204)

Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation [PDF]

Journal of Hematotherapy & Stem Cell Research, 2002
Allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective treatment for selected hematological malignancies. Its curative potential is largely mediated by an immune-mediated destruction of malignant cells by donor lymphocytes termed graft-versus-leukemia (GVL) effect.
Baron, Frédéric, Beguin, Yves
openaire   +3 more sources

Critical Role of Sensitized Serum in Rejection of Allogeneic Bone Marrow Cells

Turkish Journal of Hematology, 2014
OBJECTIVE: Humoral immunity has been clearly implicated in solid organ transplantation, but little is known about the relationship between humoral immunity and hematopoietic stem cell transplantation.
Lu Hong Xu, Jian Pei Fang, Wen Jun Weng, Hong Gui Xu   +3 more
doaj   +1 more source

Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma: a systematic review and meta-analysis

Hematology
To evaluate whether patients with multiple myeloma (MM) could benefit from tandem autologous hematopoietic stem cell transplantation (auto-HSCT), PubMed, Embase, Web of Science and Cochrane Library databases were systematically searched, and 10 eligible ...
Hongtao Li, Yaxin Zheng, Kehai Gao, Chen Tian   +3 more
doaj   +1 more source

Predictors of kidney complications and analysis of hypertension in children with allogeneic hematopoietic stem cell transplantation

, 2023
Background This study aimed to determine incidence of kidney complications in pediatric allogeneic hematopoietic stem cell transplantation (HSCT ...
ÇETİNKAYA, FAHRİYE DUYGU, TOPALOĞLU, REZAN, Gurbanov, Anar, ÖZALTIN, FATİH, KUŞKONMAZ, BÜLENT BARIŞ, GÜLHAN, BORA, DÜZOVA, ALİ, OKUR, FATMA VİSAL   +7 more
core   +1 more source

Costs of pediatric allogeneic hematopoietic‐cell transplantation [PDF]

Pediatric Blood & Cancer, 2009
AbstractBackgroundAllogeneic hematopoietic‐cell transplantation (HCT), although curative for some high‐risk diseases, is a complex and costly procedure. The costs of transplantation among children have not been described previously.ProcedureWe compared the costs of HCT within the first 100‐days among children who received myeloablative HCT from either ...
Navneet S, Majhail, Jaya M, Mothukuri, Margaret L, Macmillan, Michael R, Verneris, Paul J, Orchard, John E, Wagner, Daniel J, Weisdorf   +6 more
openaire   +2 more sources

Sinusitis in patients undergoing allogeneic bone marrow transplantation – a review

Brazilian Journal of Otorhinolaryngology
Introduction Sinusitis is a common morbidity in general population, however little is known about its occurrence in severely immunocompromised patients undergoing allogeneic hematopoietic stem cell transplantation.
Joanna Ewa Drozd-Sokolowska, Jacek Sokolowski, Wieslaw Wiktor-Jedrzejczak, Kazimierz Niemczyk   +3 more
doaj   +1 more source

Hematopoietic cell transplantation for asymptomatic X-linked lymphoproliferative syndrome type 1

Allergy, Asthma & Clinical Immunology, 2018
Background X-linked lymphoproliferative disease type 1 (XLP1) is a rare primary immune deficiency, which is caused by SH2D1A gene mutations. XLP1 is commonly associated with Epstein–Barr virus (EBV)-associated hemophagocytic lymphohistiocytosis ...
Akihiro Tamura, Suguru Uemura, Nobuyuki Yamamoto, Atsuro Saito, Aiko Kozaki, Kenji Kishimoto, Toshiaki Ishida, Daiichiro Hasegawa, Haruka Hiroki, Tsubasa Okano, Kohsuke Imai, Tomohiro Morio, Hirokazu Kanegane, Yoshiyuki Kosaka   +13 more
doaj   +1 more source

Posttransplantation course after allogeneic stem cell transplantation in a patient with advanced mycosis fungoides—Balancing relapse and rejection

JEADV Clinical Practice
Treatment of advanced cutaneous T‐cell lymphoma (CTCL) can be challenging. To date, the only potentially curative treatment option for advanced CTCL is allogeneic hematopoietic stem cell transplantation.
Inga Hansen‐Abeck, Chiara L. Blomen, Finn Abeck, Leopold Torster, Stefan W. Schneider, Nina Booken   +5 more
doaj   +1 more source

Prophylaxis of graft-versus-host-disease: Systematic evidence-based recommendations of the Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and the Brazilian society of cellular therapy and bone marrow transplantation (SBTMO)

Hematology, Transfusion and Cell Therapy
Graft-versus-host disease, involving from 20%–80% of patients, is one of the main complications of allogeneic hematopoietic cell transplantation contributing significantly to mortality and morbidity.
Afonso C. Vigorito, Carmino A. de Souza, Nelson Hamerschlak, Vaneuza A.M. Funke, Maria Claudia R. Moreira, Adriana Seber, Renato Luiz Guerino Cunha, Wanderley Bernardo, Fernando B. Duarte   +8 more
doaj   +1 more source

Kidney Transplantation After Allogeneic Hematopoietic Cell Transplantation

Kidney International Reports®
IntroductionHematopoietic stem cell transplantation (HSCT) aims to cure multiple hematologic malignancies, nonmalignant diseases, metabolic disorders, and immune deficiencies. Along with other transplant-related organ toxicities, both acute and chronic kidney disease are common complications of allogeneic HSCT, affecting 10% to 73% and 0% to 60% of ...
Ziliotis, M. J., Vauchy, C., Deconinck, E., Berceanu, A., Büchler, M., Caillard, S., Couzi, L., Dussol, B., Frimat, L., Hazzan, Marc, Jaulin, J. P., Malvezzi, P., Peffault de Latour, R., Ducloux, D., Courivaud, C.   +14 more
openaire   +5 more sources